Letter to the Editor Open Access
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Nov 26, 2024; 12(33): 6647-6649
Published online Nov 26, 2024. doi: 10.12998/wjcc.v12.i33.6647
Secondary diabetes due to different etiologies: A problem worthy of attention
Zhao Wei, Xue-Jian Wang, Department of Neurosurgery, Affiliated Hospital 2 of Nantong University, Nantong 226000, Jiangsu Province, China
ORCID number: Xue-Jian Wang (0000-0003-0389-5674).
Co-first authors: Zhao Wei and Xue-Jian Wang.
Author contributions: Wang XJ designed the overall concept, discussion and outline of the manuscript; W Zhao contributed to the discussion and design of the manuscript; Wang XJ contributed to the writing and editing of the manuscript and review of the literature.
Supported by Traditional Chinese medicine science and technology project in Jiangsu province, No. YB2015113; the Science and Technology Program of Nantong Health Committee, No. MA2019003, and No. MA2019003; Science and Technology Program of Nantong City, No. Key003, and No. JCZ2022040; Kangda College of Nanjing Medical University, No. KD2022KYJJZD019, No. KD2021JYYJYB025, and No. KD2022KYJJZD022.
Conflict-of-interest statement: All authors have no any conflicts of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xue-Jian Wang, MD, PhD, Doctor, Department of Neurosurgery, Affiliated Hospital 2 of Nantong University, No. 666 Shengli Road, Chongchuan District, Nantong 226000, Jiangsu Province, China. 6841441@163.com
Received: April 21, 2024
Revised: September 6, 2024
Accepted: September 23, 2024
Published online: November 26, 2024
Processing time: 159 Days and 0.6 Hours

Abstract

There are many factors in the occurrence of diabetes, which can result in insufficient insulin secretion and insulin receptor resistance. Including pituitary tumors, can also lead to the occurrence of diabetes, if the primary disease can not be well controlled in time, such secondary diabetes control is more difficult. In the process of clinical diagnosis and treatment, these factors need to be taken into account, timely detection and treatment of primary diseases, so as to reduce the possibility of clinical missed diagnosis.

Key Words: Editorial; Secondary diabetes; Different etiologies; Pituitary tumors

Core Tip: There are many factors in the occurrence of diabetes, which can result in insufficient insulin secretion and insulin receptor resistance. Including pituitary tumors, can also lead to the occurrence of diabetes, if the primary disease can not be well controlled in time, such secondary diabetes control is more difficult.



TO THE EDITOR

In this editorial, we present our comments on the article by Song et al[1]. Secondary diabetes is a type of diabetes that has a specific cause and is often misdiagnosed clinically as the common type 2 diabetes, especially when it is caused by some rare diseases[2]. It does not stem from problems with islet function itself, as in primary diabetes. Common causes include endocrine diseases, the use of certain drugs, genetic factors, etc., such as Williams-Beuren syndrome[3], Prader-Willi syndrome[4], pituitary adenoma, and IGG4-related diseases[5]. Four patients are listed in the form of case reports. We have also treated patients with growth hormone adenomas with diabetes, and in the course of treatment, we found a correlation between the two.

SECONDARY DIABETES ASSOCIATED WITH PITUITARY TUMORS

Pituitary tumors may lead to secondary diabetes, such as growth hormone adenomas and adrenocorticotrophin adenomas are particularly responsible for this disease[6,7]. Most of the patients with growth hormone adenoma often have serious complications such as abnormal glucose metabolism, hypertension, myocardial hypertrophy and respiratory diseases when they are treated. In addition, other axial systems of the anterior pituitary gland, such as the destruction of the gonadal axis function, seriously affect the quality and life span of patients[8]. The main metabolic function of GH is lipolysis, increasing the free fatty acids in the blood, which compete with glucose for binding sites on the muscle, inhibit glucose uptake, and produce insulin resistance, insulin signal transduction disorder is one of the main reasons for insulin resistance in type 2 diabetes patients. In addition, GH stimulates gluconeogenesis and inhibits muscle glycogen synthase. Insulin resistance is a recognized risk factor for cardiovascular diseases. Hyperinsulinemia can increase the incidence of cardiovascular diseases and mortality in patients with acromegaly. Controlling the disease and improving glucose homeostasis can reduce the incidence of cardiovascular diseases. Compared with the general population, diabetes is more likely to occur in patients with acromegaly[9], and diabetes will increase the mortality of patients with acromegaly[10].

The above examples suggest that there are many sources of secondary diabetes and that it is highly harmful. For such diseases, a comprehensive consideration should be taken in the diagnosis, including the presence of other disease bases and manifestations, as well as blood sugar levels and other relevant indicators[11].

In addition, for the treatment of some diseases, especially somatogen pituitary tumors, it is required to complete the preoperative examination of pituitary tumors, and also to clarify the possibility of other complications such as blood sugar control[12]. Clinical advice is to strengthen the control of blood sugar and basically achieve normal surgery to prevent adverse consequences. However, due to abnormally high hormones, some patients may have obvious blood sugar fluctuations, and blood sugar is not easy to control, which requires the coordination and participation of endocrinologists, neurosurgeons and other departments[13].

CONCLUSION

To sum up, clinicians should pay attention to improve the examination for the diagnosis and treatment of diseases to prevent missed diagnosis and misdiagnosis. Only by giving patients a comprehensive diagnosis and treatment can we achieve better therapeutic effect.

Footnotes

Provenance and peer review: Invited article; Externally peer reviewed.

Peer-review model: Single blind

Corresponding Author's Membership in Professional Societies: American Association for Peripheral Neurosurgery, No. 5300190.

Specialty type: Neurosciences

Country of origin: China

Peer-review report’s classification

Scientific Quality: Grade C

Novelty: Grade B

Creativity or Innovation: Grade B

Scientific Significance: Grade B

P-Reviewer: Zhang J S-Editor: Liu JH L-Editor: A P-Editor: Cai YX

References
1.  Song WR, Xu XH, Li J, Yu J, Li YX. Secondary diabetes due to different etiologies: Four case reports. World J Clin Cases. 2024;12:2813-2821.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (6)]
2.  Popoviciu MS, Paduraru L, Nutas RM, Ujoc AM, Yahya G, Metwally K, Cavalu S. Diabetes Mellitus Secondary to Endocrine Diseases: An Update of Diagnostic and Treatment Particularities. Int J Mol Sci. 2023;24.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 4]  [Reference Citation Analysis (0)]
3.  Del Chierico F, Marzano V, Scanu M, Reddel S, Dentici ML, Capolino R, Di Donato M, Spasari I, Fiscarelli EV, Digilio MC, Abreu MT, Dallapiccola B, Putignani L. Analysis of gut microbiota in patients with Williams-Beuren Syndrome reveals dysbiosis linked to clinical manifestations. Sci Rep. 2023;13:9797.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Reference Citation Analysis (0)]
4.  Driscoll DJ, Miller JL, Cassidy SB.   Prader-Willi Syndrome. 1998 Oct 6. In: GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Takahashi H, Kajita S, Katoh H, Matsumoto T, Inoue A, Sangai T, Saegusa M. Immunoglobulin G4-related thyroiditis associated with Graves' disease: A case report. Heliyon. 2024;10:e25843.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
6.  Kairys N, Anastasopoulou C, Schwell A.   Cushing Disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 202.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Yasuda ME, Renedo D, Sosa S, Danilowicz K, Recalde R, Zaninovich R, Abbati SG, Cervio A, Giovannini S, Villalonga J, Ulloque-Caamaño L, Reddy K, Socolovsky M, Campero A. Risk Factors Related to Transient Diabetes Insipidus Development Following Transsphenoidal Pituitary Adenoma Resection: A Multicentric Study. World Neurosurg. 2023;175:e636-e643.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Reference Citation Analysis (0)]
8.  Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C, van der Lely AJ, Wass J, Melmed S; Acromegaly Consensus Group. Consensus on criteria for acromegaly diagnosis and remission. Pituitary. 2024;27:7-22.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in F6Publishing: 20]  [Article Influence: 20.0]  [Reference Citation Analysis (0)]
9.  Dhaneshwar S, Shandily S, Tiwari V. Growth Hormone Excess: Implications and Management. Endocr Metab Immune Disord Drug Targets. 2023;23:748-763.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
10.  González-Virla B, Vargas-Ortega G, Romero-Gameros CA. Radiotherapy and Mortality in Pituitary Adenomas. Arch Med Res. 2023;54:102900.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
11.  Gentsch AT, Reed MK, Cunningham A, Chang AM, Kahn S, Kovalsky D, Doty AMB, Mills G, Hollander JE, Rising KL. "Once I take that one bite": the consideration of harm reduction as a strategy to support dietary change for patients with diabetes. BMC Endocr Disord. 2024;24:3.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
12.  Tritos NA. Growth hormone replacement in adults with cured acromegaly: Efficacy and safety. Best Pract Res Clin Endocrinol Metab. 2023;37:101790.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
13.  Bianchi A, Chiloiro S, Giampietro A, Gaudino S, Calandrelli R, Mazzarella C, Caldarella C, Rigante M, Gessi M, Lauretti L, De Marinis L, Olivi A, Pontecorvi A, Doglietto F. Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors. Front Endocrinol (Lausanne). 2023;14:1123267.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]